Abbott (NYSE: ABT) reported Q2 EPS of $1.31, $0.03 better than the analyst estimate of $1.28. Revenue for the quarter came in at $12.59 billion versus the consensus estimate of $12.52 billion.

GUIDANCE:

Abbott sees FY2026 EPS of $5.45-$5.60, versus the consensus of $5.48.

For earnings history and earnings-related data on Abbott (ABT) click here.